Skip to main content

Press Releases

December 1, 2023

WASHINGTON, D.C. - Today,Congressman Richard Hudson (NC-09) released the following statement:

December 1, 2023

WASHINGTON, DC - Congressman Richard Hudson (NC-09) released the following statement in recognition of the upcoming one year anniversary of the Moore County attack: 

Issues:Energy
November 30, 2023

WASHINGTON, D.C. – Today, U.S. Representative Richard Hudson (R-NC) reintroduced the Advanced Nuclear Deployment Act, legislation to amend the authorities at the Nuclear Regulatory Commission.

Issues:Energy
November 30, 2023


WASHINGTON, D.C.
– Today, U.S. Representative Richard Hudson (NC-09) announced he has named Jeff Morehouse as Leadership Chief of Staff. 

November 21, 2023

WASHINGTON, DC - Congressman Richard Hudson (NC-09) joined Members of the North Carolina Congressional Delegation in requesting answers from the U.S. Environmental Protection Agency (EPA) Administrator Michael Regan regarding the Agency's decision to allow Chemours to import GenX from their overseas facility to their facility in Fayetteville, North Carolina.

Issues:Environment
November 14, 2023

WASHINGTON, D.C. – Today, U.S. Representative Richard Hudson (NC-09) released the following statement after voting in favor of H.R. 6363, Further Continuing Appropriations and Other Extensions Act:

November 13, 2023

 

WASHINGTON, D.C. – Today, U.S. Representative Richard Hudson (NC-09) announced his resolution to designate November 12 as National Warrior Call Day, H. Res. 848, passed the House with unanimous and bipartisan support. 

Issues:Veterans
November 13, 2023


WASHINGTON, D.C. – Today, U.S. Representative Richard Hudson (NC-09) announced he has named Luke Blanchat as Chief of Staff. Blanchat will replace personal office Chief of Staff Elliott Guffin and will be based in North Carolina.

November 2, 2023

WASHINGTON, D.C. - Today, U.S. Representative Richard Hudson (NC-09) introduced the bipartisan Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act, legislation to ensure patients of rare diseases and immunodeficiencies have access to necessary plasma-based medicines.

Issues:Health Care